Haixia Cao

MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel

Dawei Sun, Ling Mao, Jun Zhang et al. · Biochemical and Biophysical Research Communications · 2015 · 99 citations

Life Sciences, Cancer Biology, Oncology +14

Exosome‑mediated gefitinib resistance in lung cancer HCC827 cells via delivery of miR‑21

Changwen Jing, Haixia Cao, Xiaobing Qin et al. · Oncology Letters · 2018 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17

Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer

Changwen Jing, Xuhua Mao, Zhuo Wang et al. · Molecular Medicine Reports · 2018 · 54 citations · Full text

Medicine, Genetics, Oncology +17

Regulation and functional role of eEF1A2 in pancreatic carcinoma

Haixia Cao, Qi Zhu, Jia Huang et al. · Biochemical and Biophysical Research Communications · 2009 · 48 citations

Medicine, Cancer Biology, Oncology +12

PPARγ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARγ/PTEN/Akt pathway

Jie Ni, Leilei Zhou, Li Ding et al. · Experimental Cell Research · 2017 · 33 citations

Medicine, Oncology, Pharmacology +12